Supreme MindSupreme Mind
1 · Before filingGatekeeper PilotKnow the expert risk before you take the case.2 · Discovery to settlementExpert Agents LiveEach side’s expert analysis and the settlement value, rerun as the facts change.3 · Expert stageReport Builder PilotYour own expert’s report, faster and harder to exclude.
One record, from intake to settlement.Use it in Claude, ChatGPT, Copilot or Word, freePilotsAPI for your tools
AntitrustSecuritiesCommercialMass TortPersonal Injury & Med MalAll Practice AreasPlaintiff FirmsDefense TeamsLitigation Funders
Expected GainsBenchmarkSample BriefResearchSecurity & Trust
Expert Agent LibraryRule 702 TrackerGuidesHow It WorksFAQ
PricingConnect
Sign inBook a demo

Cumulative exposure causation expert (asbestos)

Expert Agent Library · Mass tort and product liability · Plaintiff side

A medical or scientific causation witness who testifies that every exposure to asbestos above background added to the cumulative dose that caused an asbestos disease, so each defendant's product was a cause. Many federal courts exclude the theory, and a relabeled cumulative exposure opinion, when it is not tied to the dose from the defendant's product; some state courts admit cumulative dose testimony that stays within the science and leaves substantial factor causation to the plaintiff's exposure evidence.

A brief from this expert agent can be written for the plaintiff side, the defense side, a neutral expert, or both sides' experts on the same facts.

Ask this expertPreview

A preview of this class of expert, built from the public rulings on this page. Ask how the testimony is built, attacked or defended. 20 questions free with a firm email.

Takes a minute; we email you a code.

Questions this testimony turns on

  • How much asbestos from this defendant's product did the plaintiff inhale, and how does the expert know?
  • Does the opinion depend on the premise that any exposure above background, however brief, is a substantial cause?
  • Is the cumulative exposure opinion different in substance from an each and every exposure opinion, or only in name?
  • Did the expert account for fiber type, such as chrysotile versus amphiboles, and for the type of mesothelioma at issue?
  • Is the expert offering a medical explanation of how cumulative dose raises risk, or a legal opinion that a given exposure was a substantial factor?

Methods

  • Cumulative dose theory
  • Fiber type potency analysis
  • Exposure history review
  • Substantial factor analysis
  • Dose estimate for the defendant's product

How the testimony is attacked

  • Every exposure theory ignores dose. Defendants argue that an opinion treating every exposure as a cause ignores the principle that disease depends on dose. In Comardelle v. Pennsylvania General Insurance and Vedros v. Northrop Grumman Shipbuilding the Eastern District of Louisiana excluded specific causation opinions built on that theory.
  • Relabeling as cumulative exposure. Experts barred from the every exposure theory sometimes return with a cumulative exposure opinion. In Krik v. Exxon Mobil the Seventh Circuit upheld exclusion at trial because the new testimony was still not tied to the quantum of exposure attributable to the defendants.
  • No exposure specific to the defendant. Challengers show the expert never estimated the plaintiff's exposure to the defendant's product. In Vedros the court faulted the expert for lacking any qualitative evaluation of the plaintiff's specific exposure history, and in Rockman v. Union Carbide the court found insufficient data for a theory that ignored dose and fiber type.
  • Fiber type and disease type. Defendants argue that the opinion treats every fiber type and every form of mesothelioma alike. Rockman excluded opinions that a brief chrysotile exposure decades earlier caused peritoneal mesothelioma regardless of dose or fiber type.
  • Cumulative dose science is not the same theory. Plaintiffs answer that experts may explain that cumulative dose causes disease without saying each breath was a substantial factor. In Glenn v. 3M the South Carolina Court of Appeals accepted that line and upheld admission of cumulative dose testimony under the state's Rule 702.

What the public record shows

Courts have filed at least 49 opinions since 2015 that discuss this class of testimony and cite Daubert or Rule 702, as of October 3, 2026. 5 rulings that show how courts handle this class of testimony:

OutcomeCaseCourtYearWhy
ExcludedKrik v. Exxon Mobil Corp.870 F.3d 6697th Cir.2017The Seventh Circuit held the trial judge did not abuse his discretion in barring a cumulative exposure causation opinion as the same each and every exposure theory excluded before trial under Daubert, because it was not tied to the dose attributable to the defendants.
ExcludedComardelle v. Pennsylvania General Insurance Co.76 F. Supp. 3d 628E.D. La.2015The court excluded a pathologist's specific causation opinions resting on the every exposure theory as unreliable under Rule 702, while leaving room for testimony not based on that theory.
ExcludedVedros v. Northrop Grumman Shipbuilding, Inc.119 F. Supp. 3d 556E.D. La.2015The court excluded a physician's every exposure above background causation opinions because he did not perform a qualitative evaluation of the plaintiff's own exposure history to tie any exposure to the disease.
ExcludedRockman v. Union Carbide Corp.266 F. Supp. 3d 839D. Md.2017The court excluded specific causation opinions and the underlying theory that each exposure accumulates and counts as a cause regardless of dose, fiber type or form of mesothelioma, finding insufficient data under Rule 702.
AdmittedGlenn v. 3M Co.Op. No. 5975 (S.C. Ct. App. Apr. 5, 2023)S.C. Ct. App.2023The South Carolina Court of Appeals upheld admission of the plaintiff's experts' cumulative dose testimony under the state's Rule 702, holding it reliable and distinct from the each and every exposure theory because it explained medical causation and left substantial factor causation to the exposure evidence.

Each case links to the free opinion text on CourtListener.

In federal court: amended Rule 702

In federal court, since December 1, 2023, Rule 702 says expressly that the party offering an expert must show the court it is more likely than not that the testimony meets each requirement: that it rests on sufficient facts or data, uses reliable methods, and reflects a reliable application of those methods to the case. Questions about the basis of an opinion are no longer automatically matters of weight for the jury. For how the circuits have applied the amendment, see the Rule 702 tracker, which follows each court of appeals; for what that means for preparing or attacking this class of expert, see the guide on amended Rule 702.

Related classes

  • Specific-causation physician
  • General-causation epidemiologist
  • Toxicologist (dose-response)

Guides

  • Amended Rule 702 After Nearly Three Years: What Courts Exclude
  • General Causation in Mass Torts: Bradford Hill Under Rule 702
  • Differential Diagnosis as a Causation Method: What Courts Require

Running this expert agent on a matter

Supreme Mind’s expert agent works from a class of expert, never a named individual, on your fact pattern and returns the likely opinion, the ranked cross-examination weaknesses, the Rule 702 attack surface and what it means for settlement. Read how it works, or book a demo.

Put your questions to this expert.Ask this expertRun it on your matter →

Updated October 3, 2026. How this page is built: rulings are found by searching court opinions on CourtListener. The summaries are written by AI working from the full text of each opinion, and every citation and link is checked automatically. Outcomes are labelled by what the court did with the expert’s testimony. No individual expert is named. This page summarises public decisions for orientation and is not legal advice; read the opinion before relying on any ruling. Spotted an error? Tell us.

Gatekeeper→Expert Agents→Report BuilderOne record, from intake to settlement
Book a demo
Supreme MindSupreme Mind
AI expert witness agents for litigation, from the first screen to settlement
Products
  • Gatekeeper Pilot
  • Expert Agents
  • Report Builder Pilot
  • Pricing
  • Pilots
  • API
  • Use in Claude, ChatGPT, Copilot or Word
  • Book a Demo
Solutions
  • Antitrust
  • Securities
  • Commercial Litigation
  • Mass Tort
  • Personal Injury & Med Mal
  • All Practice Areas
  • For Funders
Why Supreme Mind
  • Expected Gains
  • Benchmark
  • Sample Brief
  • Research
  • Security & Trust
Resources
  • Expert Agent Library
  • Rule 702 Tracker
  • Guides
  • How It Works
  • FAQ
Company
  • About
  • Why Now
  • The Fourth Institution
  • Contact
© 2026 Supreme Mind AI, Inc. All rights reserved.
Terms of ServicePrivacy PolicyDPA